Molecular Basis of Tissue Identity in Cancer
Each human tissue type is characterized by a unique transcriptional landscape governed by lineage-specific transcription factors and epigenetic structures. During cancer development, genetic mutations drive transformation, yet tumors often maintain an epigenetic and transcriptional "memory" of their origin cell. This retention forms the basis for molecular classification systems in oncology.
Epigenetic markers, including DNA methylation patterns, reinforce tissue identity stability. Emerging studies indicate that methylation profiling can complement RNA-based methods for more accurate tumor classification. Understanding these signatures is fundamental to developing precision diagnostic algorithms.
MicroRNAs and other non-coding elements also contribute to maintaining tissue-specific molecular profiles in cancer, offering additional layers for diagnostic insights. These elements highlight the complexity of tissue identity beyond traditional genetics.
Bioinformatic approaches integrate these molecular data to dissect cancer mechanisms, providing a foundation for advanced classification tools.
Optimal tissue processing and microdissection enhance the accuracy of molecular profiling, ensuring reliable identification of tissue identity in cancerous samples.
Each human tissue type is defined by a unique transcriptional landscape regulated by lineage-specific transcription factors and epigenetic architecture. But to investigate how mutations in various cancer-critical genes affect tissues in a whole organism, the transgenic mouse has proved particularly useful. During oncogenesis, genetic mutations drive malignant transformation, yet many tumors retain epigenetic and transcriptional “memory” of their cell of origin. This biological principle underlies molecular classification systems
In this study, we explore the relationship between genes differentially expressed in cancer and ageing with tissue-specific identity, using data from The Cancer Genome Atlas and the Genotype-Tissue Expression project. Epigenetic markers such as DNA methylation patterns further stabilize tissue identity. Emerging research suggests methylation profiling may complement RNA-based classifiers for enhanced accuracy.
By providing a molecular portrait of an individual cancer, this technology will allow clinicians to determine the origin of the cancer, its potential for metastasis, and appropriate therapy. MicroRNAs and other non-coding elements also contribute to maintaining tissue-specific molecular profiles in cancer, offering additional layers for diagnostic insights.